Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VNDA | GLUE | ADAP | ||
| Company | Vanda Pharmaceuticals | Monte Rosa Therapeutics Inc | Adaptimmune Ther ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.50 | 5.37 | 1.0600 | ||
| High | 4.63 | 5.50 | 1.0950 | ||
| Low | 4.45 | 5.29 | 1.0300 | ||
| Last | 4.62 | 5.33 | 1.0750 | ||
| Change | +0.14 | -0.12 | +0.0150 | ||
| % Change | +3.12% | -2.20% | +1.42% | ||
| Volume | 821,900 | 87,700 | 1,162,500 | ||
| 20-Day Average Volume | 5,308,710 | 126,080 | 1,313,095 | ||
| Previous Close | 4.48 | 5.45 | 1.0600 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.54 | 6.47 | 1.1864 | ||
| 20-Day Raw Stochastic | 34.72% | 7.07% | 29.93% | ||
| 20-Day Relative Strength | 53.82% | 40.84% | 43.21% | ||
| Weighted Alpha | -18.61 | +15.01 | -47.72 | ||
| Today's Opinion | 72% Buy | 24% Buy | 24% Buy | ||
| Previous Opinion | 48% Buy | 24% Buy | 24% Buy | ||
| Last Month's Opinion | 72% Sell | 88% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.59% since 04/19/24 | -8.89% since 04/19/24 | +10.06% since 04/19/24 | ||
| Low | 4.43 on 04/25/24 | 5.11 on 04/25/24 | 0.9400 on 04/22/24 | ||
| High | 5.12 on 04/22/24 | 6.05 on 04/23/24 | 1.1600 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +19.69% since 03/26/24 | -19.12% since 03/26/24 | -29.28% since 03/26/24 | ||
| Low | 3.86 on 03/27/24 | 5.11 on 04/25/24 | 0.8721 on 04/18/24 | ||
| High | 6.03 on 04/03/24 | 8.22 on 04/09/24 | 1.6500 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +23.20% since 01/26/24 | -1.84% since 01/26/24 | +47.26% since 01/26/24 | ||
| Low | 3.46 on 02/06/24 | 4.18 on 02/13/24 | 0.7301 on 01/29/24 | ||
| High | 6.03 on 04/03/24 | 8.84 on 03/26/24 | 2.0500 on 03/08/24 | ||
| 6-Month | |||||
| %Chg | +5.24% since 10/26/23 | +113.20% since 10/26/23 | +91.96% since 10/26/23 | ||
| Low | 3.30 on 11/10/23 | 2.44 on 10/27/23 | 0.4200 on 11/28/23 | ||
| High | 6.03 on 04/03/24 | 8.84 on 03/26/24 | 2.0500 on 03/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 265,821 | 267,300 | 265,337 | ||
| Shares Outstanding, K | 57,537 | 50,150 | 246,825 | ||
| Annual Sales | 192,640,000 | 0 | 60,280,000 | ||
| Annual Net Income | 2,510,000 | -135,350,000 | -113,870,000 | ||
| Last Quarter Sales | 45,270,000 | 0 | 230,000 | ||
| Last Quarter Net Income | -2,400,000 | -33,250,000 | -47,920,000 | ||
| 60-Month Beta | 0.76 | 1.45 | 2.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 02/07/24 | -0.58 on 03/14/24 | -0.24 on 03/06/24 | ||
| Latest Earnings Date | 05/01/24 | 05/09/24 | 05/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 89.60 | 0.00 | 0.00 | ||